Richard Barry insider trades

Open-market stock purchases and sales by Richard Barry, President & CEO at Filana Therapeutics, Inc, from SEC Form 4 filings since Dec 12, 2012.

Track record: 19% of 21 scored buys are up 5% or more since purchase, averaging -46%.

Recent trades

DateStockTradeValue
Sep 30, 2026FLNA Filana Therapeutics, IncBought$92K
Sep 29, 2026FLNA Filana Therapeutics, IncBought$186K
Sep 28, 2026FLNA Filana Therapeutics, IncBought$78.2K
Jun 4, 2026SRPT Sarepta Therapeutics, IncBought (not open market)—
Nov 20, 2025SAVA Cassava Sciences IncBought$414K
Nov 19, 2025SAVA Cassava Sciences IncBought$202K

Companies traded

  • FLNA Filana Therapeutics, Inc: 3 buys, last Sep 30, 2026
  • SRPT Sarepta Therapeutics, Inc: 8 buys, 5 sales, last Jun 4, 2026
  • SAVA Cassava Sciences Inc: 12 buys, last Nov 20, 2025
  • MDXG Mimedx Group, Inc: other filings, last Aug 5, 2020
  • TELK Telik Inc: 3 sales, last Dec 17, 2012

Get free alerts when Richard Barry files a new trade →